Posts by: Isaura Santos

Isaura Santos

Isaura Santos graduated with a BS in Cell and Molecular Biology from Universidade Nova de Lisboa and a MA in Communication, Culture and Information Technologies from University Institute of Lisbon (ISCTE-IUL). Her professional interests include science communication, public awareness of science and communication of science through entertainment.

June 16, 2017September 4, 2019

12 Facts About Pulmonary Fibrosis Prognosis and Life Expectancy

Idiopathic Pulmonary Fibrosis, Social Clips

Pulmonary fibrosis (PF) is a chronic and progressive lung disease where the air sac in the lungs (alveoli) becomes scarred and stiff making it difficult to breathe and get enough oxygen ... Read more

June 16, 2017August 30, 2017

6 Famous People Who Lost Their Battle With Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis, Social Clips

Pulmonary fibrosis (PF) is a chronic lung disease where the tissue in the lungs becomes scarred and stiffens over time. Like all diseases, PF does not discriminate and there have ... Read more

April 14, 2017April 18, 2017

4 Breathing Mistakes You’re Probably Making

We breathe every day. For some of us, this process is simple and we don’t think too much about it. For others, it’s a constant struggle that requires a lot ... Read more

August 31, 2015November 5, 2015

Pulmonary Fibrosis Foundation & Veracyte Partner To Advance Interstitial Lung Disease Survey

Idiopathic Pulmonary Fibrosis, News

The Pulmonary Fibrosis Foundation (PFF) and Veracyte, Inc have recently announced they are partnering on a survey for United States patients in order to develop better insights concerning patients’ diagnostic experiences with interstitial lung diseases ... Read more

August 25, 2015November 5, 2015

Kitabis Pak Named 1 Of The 10 Notable Drug-Device Approvals Of 2014

Cystic Fibrosis, News

Kitabis Pak, the first co-packaging of generic tobramycin inhalation solution with a PARI LC PLUS Nebulizer to address cystic fibrosis, was recently listed among ten notable drug-device approvals of 2014, published in ... Read more

August 25, 2015August 25, 2015

DelMar Pharmaceuticals Will Present VAL-083 Lung Cancer Clinical Strategy

Lung Cancer, News

DelMar Pharmaceuticals, Inc., a biopharmaceutical firm focused on the advancement and commercialization of novel cancer therapies, recently announced it has been invited to present a clinical strategy overview concerning VAL-083 (dianhydrogalactitol) and its potential as a treatment for patients ... Read more

August 24, 2015November 9, 2015

USPSTF Recommends Against COPD Screening In People Who Are Asymptomatic

COPD

The United States Preventive Services Task Force (USPSTF) has recommended against primary care screening for chronic obstructive pulmonary disease (COPD) in adults who are not symptoms indicative of the disease, according to a ... Read more

August 21, 2015November 6, 2015

Raptor Pharmaceutical Expands Its Rare Disease Portfolio For CF, Bronchiectasis By Acquiring Quinsair

Bronchiectasis, News

Raptor Pharmaceutical Corp. recently announced it has signed an agreement with Tripex Pharmaceuticals in order to acquire Quinsair, which is the first inhaled fluoroquinolone that received approval to manage chronic pulmonary infections caused Pseudomonas ... Read more

August 20, 2015August 21, 2015

American Lung Association & Inspire Working Together To Support Lung Cancer Patients

Lung Cancer, News

The American Lung Association is collaborating with Inspire’s online community to create a new digital resource for both caregivers and patients who have been affected by lung cancer. “The American Lung Association is committed to ... Read more

August 20, 2015November 6, 2015

Resunab Receives Fast Track FDA Status To Treat Scleroderma

News, Scleroderma

Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development firm committed to addressing chronic, rare and serious inflammatory and fibrotic diseases, recently announced that the United States Food and Drug Administration (FDA) has ... Read more